Football bodies could be forced to pay towards brain injury care costs of ex-players
Football bodies could be forced to pay towards the care costs of ex-players who have been diagnosed with brain conditions, under proposals set to be considered by MPs.
Campaigners are drafting amendments to the Football Governance Bill, which would treat conditions caused by heading balls as an "industrial injuries issue".
The proposals seek to require the football industry to provide the necessary financial support.
Campaigners say existing support is not fit for purpose, including the Brain Health Fund which was set up with an initial £1m by the Professional Footballers' Association (PFA), supported by the Premier League.
But the Premier League said the fund has supported 121 families with at-home adaptations and care home fees.
From England 's 1966 World Cup-winning team, both Jack and Bobby Charlton died with dementia, as did Martin Peters, Ray Wilson and Nobby Stiles.
Ex-players, including former Liverpool defender Neil Ruddock, went to parliament last week to lobby MPs.
Ruddock told Sky News he had joined campaigners "for the families who've gone through hell".
"A professional footballer, greatest job in the world, but no one knew the dangers, and that's scary," he said.
"Every time someone heads a ball it's got to be dangerous to you. You know, I used to head 100 balls a day in training. I didn't realise that might affect my future."
A study co-funded by the PFA and the Football Association (FA) in 2019 found footballers were three and a half times more likely to die of a neurodegenerative disease than members of the public of the same age.
'In denial'
Among those calling on football authorities to contribute towards the care costs of ex-players who have gone on to develop conditions such as Alzheimer's and dementia is Labour MP Chris Evans.
Mr Evans, who represents Caerphilly in South Wales, hopes to amend the Bill to establish a care and financial support scheme for ex-footballers and told a recent event in parliament that affected ex-players "deserve to be compensated".
Greater Manchester Mayor Andy Burnham, who helped to draft the amendment, said the game was "in denial about the whole thing".
Mr Burnham called for it to be seen as "an industrial injuries issue in the same way with mining".
In January, David Beckham lent his support to calls for greater support for footballers affected by dementia.
One of the amendments says that "the industry rather than the public should bear the financial burden".
A spokesperson for the FA said it was taking a "leading role in reviewing and improving the safety of our game" and that it had "already taken many proactive steps to review and address potential risk factors".
An English Football League spokesperson said it was "working closely with other football bodies" to ensure both professional and grassroots football are "as safe as it can be".
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
4 hours ago
- Scottish Sun
The 52p herb that could help prevent Alzheimer's – plus 3 other ways it can benefit your health
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) KNOWN for its strong, pine-like flavour and its use in various dishes, rosemary has a lot more going for it than its scent and taste. The popular herb is starting to gain recognition for its impressive health benefits, especially when it comes to brain health, inflammation and immune function. Sign up for Scottish Sun newsletter Sign up 2 Rosemary has been shown to benefit the brain in several ways Credit: Getty And research published this year suggests it could even help in the fight against Alzheimer's disease - the leading cause of dementia worldwide. Rosemary has previously been linked to memory and mental clarity. In ancient Greece and Rome, students and scholars used rosemary to sharpen concentration and recall, says Dipa Kamdar, senior lecturer in pharmacy practice at Kingston University. Writing for The Conversation, she explains: "Modern science is finding there may have been something in this: in one study, people who inhaled rosemary's scent performed better on memory takes compared to those in an unscented environment." There are several ways rosemary benefits the brain, says Kamdar. Firstly, it stimulates blood circulation, including to the brain, helping deliver more oxygen and nutrients, which may improve mental clarity. It also has calming properties, with some studies suggesting its aroma can reduce anxiety and improve sleep - lower stress means better focus and memory retention. Kamdar adds: "Rosemary contains compounds that interact with the brain's neurotransmitters. One such compound, 1,8-cineole, helps prevent the breakdown of acetylcholine, a brain chemical essential for learning and memory. By preserving acetylcholine, rosemary may help support cognitive performance, especially as we age." And rosemary's antioxidants may also help protect brain cells from damage caused by oxidative stress - which is a major factor in cognitive decline. Kamdar says: " Rosemary is rich in phytochemicals, plant compounds with health-enhancing effects. One of the most powerful is carnosic acid, an antioxidant and anti-inflammatory agent that helps shield brain cells from harm, particularly from the kinds of damage linked to Alzheimer's disease." Five simple tests that could indicate dementia What are rosemary's benefits beyond brain health? 2 Rosemary may aid digestion by stimulating the liver to produce bile Credit: Getty As well as boosting brain health, studies suggest rosemary may aid digestion by stimulating the liver to produce bile, which helps the body digest fat. In a study with mice, it was shown to reduce inflammation in the digestive tract, potentially aiding in the management of IBS and other inflammatory bowel ailments. And rosemary supplementation may also positively impact the gut microbiota, increasing beneficial bacteria like Bifidobacterium and Bacteroidetes, while reducing harmful bacteria like Escherichia coli. Rosemary may also be able to improve immune function. Some studies, particularly in vitro and animal models, suggest that rosemary and its active compounds, like carnosic acid and rosmarinic acid, can influence immune function. Other studies have shown rosemary may promote immune cell activity, such as increasing antibody production or enhancing the activity of immune cells like dendritic cells. Finally, rosemary could prevent certain cancers. Rosemary has been proven to display powerful anticancer efficacy in numerous cancers, including lung, prostate, liver, and breast. Carnosic acid appears to be the plant's primary anticancer component, as it was found in one study to exhibit antiproliferative effects in cancer cells.
STV News
5 hours ago
- STV News
Alzheimer's research suffers 'devastating blow' after new drug rejected by NHS
A woman who has Alzheimer's disease has said the progression of research has suffered a 'devastating blow' after a new drug was rejected for use by NHS Scotland. Donanemab delays the onset of dementia and works by targeting a cause of the disease, rather than just treating its symptoms. But the Scottish Medicines Consortium says there isn't enough evidence to prove how well it works. Recently retired Rynagh has lived an enviable life, growing up in Ireland, moving to the US, and attending New York University. Coming to Scotland, she expected to live out the rest of her life in peaceful retirement. Instead, she found out she had dementia. She's now thrown into finding a cure for Alzheimer's – and says the rejection of this drug is a massive blow. 'What would it take to approve a drug for dementia?', she said. 'Because it seems to be a lost in space for people. There aren't annual check-ups or anything like there are with other diseases. So there's no record of decline, which is unusual when you think about how progress is made with other diseases over time. 'Think about polio, leprosy, and cancer. They were known many years ago, but we don't talk about them because of the needs and the cost. 'And I understand that cost is a factor, but the burden on society, even in comparison to those other diseases, is tremendous. Absolutely. And only tremendous. It's not just the individual, it's the community, it's the family. 'It's the cost to the next generation for what they lose out by having to provide that care and not being able to support their own families, immediate families, in the way that they will.' Donanemab works when antibodies are given by infusion into a vein in the arm – they then bind with amyloids in the brain, a protein that builds up in Alzheimer's patients, and leads to cognitive decline. Those antibodies trigger immune cells, which clear the amyloid – and slow down the alzheimer's process. The Scottish Medicines Consortium rejected donanemab for use on the NHS as it said there wasn't 'enough evidence of how well it works.' Meanwhile manufacturer Lilly claims the decision 'does not consider … the clinical efficacy and cost-effectiveness' of the drug. It's left campaigners worried about the future of dementia research. Henry Simmons, chief executive of Alzheimer Scotland, said: 'The process that all drugs go through at present at the both the NHS in Scotland and England is a reasonable process however, we don't think it is a reasonable way to tackle the issues we face in terms of the size and scale of dementia, and what we are calling for is a rethink on that.' There's hope the SMC will reconsider the drug, but in the meantime, Rynagh hopes people living with dementia don't give up – and that awareness of the illness continues to grow. 'Well, when it comes down to it, it is the public', she added. 'And if the public doesn't have the awareness, they won't push. 'You know, like 66% is that about two thirds of people with dementia are women. Women typically are the caregivers, but then they need the care and it becomes this cycle and it is increasing instead of decreasing. 'And also with the population pyramid is kind of changing as well. We know that that the elderly population is getting bigger and that's it's a disaster that you should be able to see. 'It's not that you're seeing one seventh of the iceberg. We're now coming to the point where it's so far above the water, it should be that you can go around us and go through it and disperse it, but are not even talking about it at the level that we need to be talking about it.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country
Glasgow Times
8 hours ago
- Glasgow Times
Around 1,000 doctors urge MPs to vote against ‘unsafe' assisted dying Bill
The Terminally Ill Adults (End of Life) Bill will return to the House of Commons for debate on Friday, with MPs expected to consider further amendments. But in a letter, published this week, doctors from across the NHS have urged lawmakers to listen to those 'who would have to deliver the consequences of this deeply flawed Bill'. They warn the Bill 'poses a real threat to both patients and the medical workforce'. In its current form the proposed legislation, which applies only to England and Wales, would mean terminally ill adults with only six months left to live could apply for assistance to end their lives, subject to the approval of two doctors and an expert panel. Last month, MPs approved a change in the Bill to ensure no medics would be obliged to take part in assisted dying. Doctors already had an opt-out but the new clause extends that to anyone, including pharmacists and social care workers. Encouraging or assisting suicide is currently against the law in England and Wales, with a maximum jail sentence of 14 years. The letter to MPs said: 'As experienced medical professionals who regularly work with dying patients and who have reviewed the worldwide evidence on assisted dying, it is our opinion that this Bill poses a real threat to both patients and the medical workforce, and we urge you to vote against it. 'We are concerned that the private member's Bill process has not facilitated a balanced approach to the collection of evidence and input from key stakeholders including doctors, people with disabilities and other marginalised groups. 'This Bill will widen inequalities, it provides inadequate safeguards and, in our collective view, is simply not safe. 'This is the most important piece of healthcare legislation for 60 years and we urge you to listen to the doctors who would have to deliver the consequences of this deeply flawed Bill.' Sir Ed Davey welcomed the letter on Monday, telling Sky News he had 'real concerns'. 'I have voted against this assisted dying legislation, as I did on previous occasions,' the Liberal Democrat leader said. 'I have real concerns about the pressure on individuals, that they will put on themselves, if they think they are a burden on their family, so I welcome this letter.' He added: 'I hope, as time has gone on, as the arguments have been better exposed, that MPs will switch sides and join the side that I and many MPs are on.' But Sir Chris Bryant said he would be voting in favour. The technology minister told Sky News: 'The Government doesn't have a formal position at all and individual members are free to choose how they vote. 'I'm not going to hide my own personal preference. I abstained on the first time round, I decided I wasn't going to vote because I wanted to hear the debate. 'I have listened to a lot of the debate. Of course, I don't want anybody to feel that they are a burden on society and that should lead them towards taking their own life, but I also have heard the cries of people who are absolutely miserable, and that's why I will be voting for the Bill.' Some of the Bill's opponents have urged MPs to focus on improving end-of-life care rather than legislating for assisted dying. Ahead of last month's Commons debate on the Bill, two royal medical colleges raised concerns over the proposed legislation. The Royal College of Physicians (RCP) said it believes there are 'concerning deficiencies', while the Royal College of Psychiatrists (RCPsych) said it has 'serious concerns' and cannot support the Bill. People with terminal illnesses, surrounded by loved ones, display their dying wishes on tags outside the Palace of Westminster in London to urge MPs to support the Terminally Ill Adults (End of Life) Bill (Jas Lehal/PA) Opinions among members of the medical profession remain varied, with TV doctor Hilary Jones describing assisted dying for the terminally ill as 'kind and compassionate', adding that he would help a patient to end their life if the law was changed. The GP, often seen on ITV's Good Morning Britain and the Lorraine show, told the PA news agency he believes medicine will go 'back to the Dark Ages' if proposed legislation being considered at Westminster is voted down. While Friday is expected to see debate on further amendments to the Bill, it is thought a vote on the overall legislation might not take place until the following Friday, June 20.
